Role of the dysfunctional ryanodine receptor - Na+-Ca2+exchanger axis in progression of cardiovascular diseases: What we can learn from pharmacological studies?

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Abnormal Ca2+homeostasis is often associated with chronic cardiovascular diseases, such as hypertension, heart failure or cardiac arrhythmias, and typically contributes to the basic ethiology of the disease. Pharmacological targeting of cardiac Ca2+handling has great therapeutic potential offering invaluable options for the prevention, slowing down the progression or suppression of the harmful outcomes like life threatening cardiac arrhythmias. In this review we outline the existing knowledge on the involvement of malfunction of the ryanodine receptor and the Na+-Ca2+exchanger in disturbances of Ca2+homeostasis and discuss important proof of concept pharmacological studies targeting these mechanisms in context of hypertension, heart failure, atrial fibrillation and ventricular arrhythmias. We emphasize the promising results of preclinical studies underpinning the potential benefits of the therapeutic strategies based on ryanodine receptor or Na+-Ca2+exchanger inhibition.

Original languageEnglish
Pages (from-to)91-101
Number of pages11
JournalEuropean Journal of Pharmacology
Volume779
DOIs
Publication statusPublished - May 15 2016

Keywords

  • Cahomeostasis
  • Cardiac arrhythmia
  • Heart failure
  • Intracellular Caconcentration
  • Na-Caexchanger
  • Ryanodine receptor

ASJC Scopus subject areas

  • Pharmacology

Fingerprint Dive into the research topics of 'Role of the dysfunctional ryanodine receptor - Na<sup>+</sup>-Ca<sup>2+</sup>exchanger axis in progression of cardiovascular diseases: What we can learn from pharmacological studies?'. Together they form a unique fingerprint.

  • Cite this